Cyteir Therapeutics welcomes John Thero to its Board of Directors
– USA, MA – Cyteir Therapeutics, Inc. (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced the appointment of John Thero to its board of directors, bringing the board directors from eight to nine members.…